MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A8245 Sorafenib Tosylate1 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
- A1632 SB202190 (FHPI)5 CitationTarget: p38Summary: P38 MAPK inhibitor
- A5566 LY22288201 CitationTarget: p38Summary: P38 MAP kinase inhibitor
- A5573 Pimasertib (AS-703026)Target: MEKSummary: MEK1/2 inhibitor
- A1947 MEK162 (ARRY-162, ARRY-438162)Target: MEKSummary: MEK1/2 inhibitor,potent and selective
- A8716 LY3009120Target: RafSummary: pan-RAF and RAF dimer inhibitor
- A3018 Trametinib (GSK1120212)7 CitationTarget: MEKSummary: MEK1 and MEK2 inhibitor, potent and selective